Trophic serves as a strategic partner for all aspects of communications for life science companies. We apply a deep understanding of both the science and business of drug development and the capital needed for success. Based on breadth and depth of experience, Trophic has become the go-to advisory for presenting corporate stories and scientific concepts. Current client portfolio ranges from biotech start-ups, listed biopharmas and small and large pharmaceutical companies.

TROPHIC TWITTER FEED

Follow us on Twitter to stay tuned on biotech news and the inner workings of the Trophic team

Congratulations to @ImcheckThx on their $53M #SeriesB led by @Bpifrance & @pfizer! It has been a pleasure to support this fundraising & we look forward to @ImcheckThx advancing their 1st #cancer #mAb, ICT01, that activates #gammadeltaTcells into the clinic.

Congratulations to @ImcheckThx on their $53M #SeriesB led by @Bpifrance & @pfizer! It has been a pleasure to support this fundraising & we look forward to @ImcheckThx advancing their 1st #cancer #mAb, ICT01, that activates #gammadeltaTcells into the clinic.
ImCheck Therapeutics@ImcheckThx

@ImcheckThx Raises $53 Million #SeriesB to Advance #ClinicalPipeline of Novel #gdTcell -Focused #mAbs for #Cancer & #AutoimmuneDiseases
@Bpifrance @pfizer @wellingtonvc #AgentCapital #AlexandriaVenture #LSP @Gimv @idinvest @KurmaPartners @Boehringer https://t.co/IQwPYQpcND

As #Thanksgiving & November come to an end, our #officedog, Bean asks: ๐Ÿwhat are you #thankful for?๐Ÿ‚ Let us know in the comments. We at Trophic can think of a few things: Bean wearing a beanie, smooth #JPM #scheduling, and the start of #christmasmarket season here in #Munich

A certain Managing Director at a certain PR/IR agency is in the process of celebrating her #birthdayweek & we are along for the ride! 3 cakes do not even begin to express our gratitude for @GLPSchweitzer & her talent as a boss, mentor & professional communicator. #happybirthday

Load More...